These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38081477)

  • 1. Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation.
    Wang M; Wang J; Wang L; Feng X; Qian Y; Ye C; Wang C
    Phytother Res; 2024 Feb; 38(2):839-855. PubMed ID: 38081477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys.
    Wang M; Wang L; Zhou L; Xu Y; Wang C
    Phytomedicine; 2024 Apr; 126():155450. PubMed ID: 38368794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Icariin improves renal interstitial fibrosis in a rat model of chronic renal failure by regulating mitochondrial dynamics].
    Wang M; Wang LC; Feng XX; Zhou Y; Ye CY; Wang C
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2170-2177. PubMed ID: 35531733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shen Shuai II Recipe inhibits hypoxia-induced glycolysis by preserving mitochondrial dynamics to attenuate kidney fibrosis.
    Wang L; Feng X; Ye C; Wang C; Wang M
    J Ethnopharmacol; 2023 May; 308():116271. PubMed ID: 36806483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
    Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
    Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of PPAR
    Chung KW; Lee EK; Lee MK; Oh GT; Yu BP; Chung HY
    J Am Soc Nephrol; 2018 Apr; 29(4):1223-1237. PubMed ID: 29440279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial-mesenchymal transition
    Hsieh YH; Tsai JP; Ting YH; Hung TW; Chao WW
    Food Funct; 2022 Apr; 13(8):4641-4652. PubMed ID: 35373225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.
    Comella F; Lama A; Pirozzi C; Annunziata C; Piegari G; Sodano F; Melini S; Paciello O; Lago Paz F; Meli R; Mattace Raso G
    Biomed Pharmacother; 2024 Feb; 171():116094. PubMed ID: 38183745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis.
    Wang JL; Chen CW; Tsai MR; Liu SF; Hung TJ; Yu-Ju-Hung ; Chang WT; Shi MD; Hsieh PF; Yang YL
    Exp Cell Res; 2018 Sep; 370(1):160-167. PubMed ID: 29913155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway.
    Zhang L; Wang X; He S; Zhang F; Li Y
    J Ethnopharmacol; 2023 Jul; 311():116466. PubMed ID: 37031821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis.
    Poolsri W; Noitem R; Jutabha P; Raveesunthornkiat M; Danova A; Chavasiri W; Muanprasat C
    Biomed Pharmacother; 2023 Sep; 165():115098. PubMed ID: 37437378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of fatty acid oxidation led by Hilpda increases G2/M arrest/delay-induced kidney fibrosis.
    Liu L; Liu T; Jia R; Zhang L; Lv Z; He Z; Qu Y; Sun S; Tai F
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166701. PubMed ID: 36990128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.
    Jao TM; Nangaku M; Wu CH; Sugahara M; Saito H; Maekawa H; Ishimoto Y; Aoe M; Inoue T; Tanaka T; Staels B; Mori K; Inagi R
    Kidney Int; 2019 Mar; 95(3):577-589. PubMed ID: 30639234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
    Lyu H; Li X; Wu Q; Hao L
    J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
    Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
    PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation.
    Chen DQ; Chen L; Guo Y; Wu XQ; Zhao TT; Zhao HL; Zhang HJ; Yan MH; Zhang GQ; Li P
    Acta Pharmacol Sin; 2023 May; 44(5):1038-1050. PubMed ID: 36470978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolic Compounds from
    Ruan Y; Yuan PP; Wei YX; Zhang Q; Gao LY; Li PY; Chen Y; Fu Y; Cao YG; Zheng XK; Feng WS
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.
    Zhang W; Song S; Liu F; Liu Y; Zhang Y
    Peptides; 2015 Aug; 70():37-44. PubMed ID: 25882007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.